Vancomycin is an antibiotic frequently used in the treatment of MRSA (Methacillin resistant Staphylococcus aureus).
In podiatry and orthopaedics, Vancomycin is the most commonly used intravenous antibiotic for the treatment of MRSA soft tissue infections and MRSA osteomyelitis. The most recent studies have suggested a 10 to 20-fold increase in the use of Vancomycin in the past 25 years. 1, 2 There are a number of drugs that can cause thrombocytopenia. 3 Very often, patients who are on prolonged IV antibiotic treatment are also placed on Heparin to prevent DVT (deep vein thrombosis) and pulmonary embolism. Heparin, or Lovanox®, has been implicated in causing thrombocytopenia in such cases.
In this setting, thrombocytopenia is characterized by an acute drop in the platelet count. In the combined use of Vancomycin and Heparin, it is often difficult to determine whether the thrombocytopenia is caused by Vancomycininduced immune antibodies or a Heparin-induced response.
In a recent study of The patient's medication list was extensive. The patient was on Coreg 25mg, Lasix 40mg , Digitek 0.125mg, Avandia 4mg, Lisinopril 5mg, Glyburide 5mg, KCl 20 meq, Allopurinol 300mg, Welchol 650mg, Zetia 10mg, Indomethacin 25mg prn for gout, Prevacid 30mg, Aspirin 81mg, Quinine 325mg prn for leg cramps, Viagra 100mg, Calcium 600mg and Glucosamine/Chondritin 500/400.
The patient did not take any Glucosamine or Chondritin while in hospital. Vancomycin peaks and troughs were run on two separate days. Peaks were 28.5 and 36.6 mcg/m and troughs were 17.3 and 13.4 mcg/ml. The infection cleared after surgery; however, on the 10 th day of treatment, he began to loose his appetite and developed spiking fevers. His fever peaked to 102.5 Fahrenheit with ensuing petechiael rash of his back and arms. (Fig. 1 At this writing, there is only one laboratory in the country that can test for this antibody at this writing. The plasma was sent to the BloodCenter of Wisconsin. He was given 10 units of platelets without response. After the second day, the patient's platelets only increased to 3 x 10 3 /mm 3 . He also developed a nose-bleed, which was stopped by local packing. He was then given IV dexamethasone, Immunoglobulins and Epogen. After the fourth day, his platelets increased to 15 x 10 3 /mm 3 . By the end of the week, the patient's platelet count was over 100 x 10 3 /mm 3 .
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Laboratory Assay
The Laboratory tested for both IgG and IgM in the patient's serum with and without Vancomycin present.
( Vancomycininduced thrombocytopenia has rarely been reported in the literature. This appears to be the first report of Vancomycin-induced thrombocytopenia in the podiatry literature. The mechanism of drug-induced thrombocytopenia is one of immunological platelet destruction. The drug will bind to the fragment antigen binding (FAB) portion of an antibody.
The antibodies will then attach to the drugplatelet complex and cause platelet destruction through complement activation. 5, 6, 7 In Vancomycin-induced thrombocytopenia, the immunologic response is through hapten formation.
There is now compelling evidence that patients who develop Vancomycin-induced thrombocytopenia have Vancomycin-dependent antibodies. 5, 6 As late as 2003, Vancomycin-induced thrombocytopenia was confirmed by rechallenge of the medication or when heparin-induced thrombocytopenia was ruled out. 4, 5, 6 .
Heparin induced thrombocytopenia is associated with a strongly positive human platelet factor 4 (PF4). This can be tested by ELISA (Enzyme-Linked ImmunoSorbent Assay) and often returns to normal after the Heparin is stopped. 5 Many times, Vancomycin and Heparin are given concurrently in cardiac patients or patients who may require prolonged bed rest. In this case report, both Lovanox® and Vancomycin is discontinued. Platelets were initially transfused during the acute phase in an attempt to increase platelet levels. This did not seem to cause any rise in platelet levels. Von Drygalski, et al., reported similar results in 11 of 14 patients who received platelet transfusions. 5 It could be theorized that circulating antibodies will continue to support a platelet destructive affect making platelet transfusions ineffective in the acute phase of thrombocytopenia. Antibodies can also persist for many months after exposure to Vancomycin. 5 Once the Vancomycin is stopped, in most circumstances, the platelet levels will normalize within 7 days. 6 This case confirms similar results reported by Von Drygalski, et al. It is also conclude that the use of drug-dependent antibody assays can identify and confirm the cause of thrombocytopenia in patients who show a precipitous drop in platelet levels while receiving Vancomycin.
